|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：L329800 |
| 產(chǎn)品名稱：Lestaurtinib |
| 產(chǎn)品CAS：111358-88-4 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
L329800 |
| 名稱: |
Lestaurtinib |
| 別名: |
(9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3’,2’,1’-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one; A 154475.0; CEP 701 ; KT 5555; SP 924; |
| CAS號: |
111358-88-4 |
| 分子式: |
C??H??N?O? |
| 外觀: |
白色至Yellow Solid |
| 熔點(diǎn): |
>186°C (dec.) |
| 分子量: |
439.46 |
| 儲(chǔ)存: |
Amber Vial, -20°C Freezer, Under Inert Atmosphere |
| 溶解度: |
Chloroform (Slightly, Heated), Methanol (Slightly) |
| 穩(wěn)定性: |
Photosensitive |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
It is used for the treatment of pancreatic cancer and acute myelogenous leukaemia (AML). |
| 參考文獻(xiàn) |
|
|
|
|
|
|
?您的位置：
